Bar-Peled Lab | Massachusetts General Hospital
Research in the Bar-Peled laboratory sits at the interface of cellular metabolism and signal transduction and focuses on understanding how cancer cells respond to altered metabolic states.
Research in the Bar-Peled laboratory sits at the interface of cellular metabolism and signal transduction and focuses on understanding how cancer cells respond to altered metabolic states.
The Nabeel M. Bardeesy, PhD Laboratory focuses on defining the pathways driving the pathogenesis of pancreatic and biliary cancers.
The lab is designed to provide a collaborative resource that can provide expertise and services on tissue acquisition, preparation, specialized histological stains, and high-end digital microscopy quantitative analysis.
The Division of Biostatistics & Biomathematics supports research-oriented databases and data management needs for Radiation Oncology.
The Bod laboratory focuses on deciphering the landscape of phenotypic and functional B cell states within tumors.
The Boland Lab at Massachusetts General Hospital leads correlative immuno-oncology efforts in melanoma and gastrointestinal malignancies.
The Brastianos laboratory studies genomic drivers of human brain tumors.
The Cancer Outcomes Research and Education Program (CORE) conducts innovative research and educational programs to improve the experience and outcomes of patients and caregivers across the continuum of cancer care.
The Caregiving Research Program seeks to address the emotional and physical toll of cancer caregiving by studying ways to support the family and friend caregivers of patients at Mass General Cancer Center.
Working at the cellular and molecular levels, our studies cover a range of topics, including mechanisms of cell death, DNA damage induction and repair processes, bystander effects, and cancer genetics.
Our commitment to eradicating cancer is fueled by scientific investigation as part of the largest hospital-based research program in the United States.